Nifty

:

22147.90

Sensex

:

72943.68

-124.60 (-0.56%)
-456.10 (-0.62%)

Login

Nifty
Sensex

:
:

22147.90
72943.68

-124.60 (-0.56%)
-456.10 (-0.62%)

Medicamen Biotech Ltd.

Pharmaceuticals & Drugs - Global

Rating :

38/99

BSE: 531146 | NSE: MEDICAMEQ

Watchlist

NSE BSE

417.85

16-Apr-2024

Open
High
Low
Previous Close

417.40
422.00
415.00
415.85

Volume
Traded Value (lacs)
52 Week High
52 Week Low

6141
25.71
845.00
355.45

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

532.36
42.97
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

547.95
0.24%
2.66

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

6.53
2.82
7.71

EBITDA CAGR (%)

10 Years
5 Years
3 Years

16.75
6.87
4.34

PAT CAGR (%)

10 Years
5 Years
3 Years

66.80
4.13
6.69

P:E (Median)

8 Years
5 Years
3 Years

55.76
57.37
58.08

P:BV (Average)

8 Years
5 Years
3 Years

4.70
5.31
5.45

EV:EBITDA (Average)

8 Years
5 Years
3 Years

30.60
34.67
35.90

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 44.20 34.12 29.54% 42.67 33.53 27.26% 40.50 33.09 22.39% 37.15 22.75 63.30%
Expenses 38.62 28.25 36.71% 36.52 27.68 31.94% 33.09 27.43 20.63% 30.38 17.78 70.87%
EBITDA 5.58 5.87 -4.94% 6.15 5.85 5.13% 7.41 5.66 30.92% 6.77 4.98 35.94%
EBIDTM 12.63% 17.19% 14.42% 17.46% 18.30% 17.10% 18.22% 21.87%
Other Income 0.83 0.63 31.75% 0.55 0.53 3.77% 0.38 0.96 -60.42% 0.35 0.34 2.94%
Interest 0.65 0.68 -4.41% 0.91 0.62 46.77% 0.96 0.77 24.68% 0.86 0.56 53.57%
Depreciation 1.76 1.60 10.00% 1.80 1.61 11.80% 1.68 1.53 9.80% 1.61 1.52 5.92%
PBT 4.01 4.21 -4.75% 4.00 4.15 -3.61% 5.15 4.33 18.94% 4.65 3.23 43.96%
Tax 1.24 0.45 175.56% 0.99 0.54 83.33% 0.74 0.74 0.00% 0.60 0.47 27.66%
PAT 2.77 3.76 -26.33% 3.01 3.61 -16.62% 4.42 3.59 23.12% 4.05 2.75 47.27%
PATM 6.26% 11.02% 7.06% 10.77% 10.91% 10.84% 10.89% 12.10%
EPS 2.18 2.96 -26.35% 2.37 2.84 -16.55% 3.48 2.82 23.40% 3.19 2.17 47.00%

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 46.50 35.58 30.69% 43.54 33.53 29.85% 41.94 33.09 26.75% 38.66 22.75 69.93%
Expenses 41.61 29.71 40.05% 38.90 27.68 40.53% 34.99 27.43 27.56% 32.17 17.79 80.83%
EBITDA 4.89 5.88 -16.84% 4.65 5.85 -20.51% 6.95 5.66 22.79% 6.49 4.97 30.58%
EBIDTM 10.52% 16.51% 10.67% 17.44% 16.57% 17.10% 16.79% 21.83%
Other Income 0.83 0.63 31.75% 0.55 0.53 3.77% 0.38 0.96 -60.42% 0.35 0.34 2.94%
Interest 0.65 0.68 -4.41% 0.91 0.62 46.77% 0.96 0.77 24.68% 0.86 0.56 53.57%
Depreciation 1.81 1.60 13.12% 1.82 1.61 13.04% 1.69 1.53 10.46% 1.62 1.52 6.58%
PBT 3.27 4.22 -22.51% 2.46 4.14 -40.58% 4.68 4.33 8.08% 4.36 3.22 35.40%
Tax 1.24 0.45 175.56% 0.99 0.54 83.33% 0.74 0.74 0.00% 0.59 0.47 25.53%
PAT 2.03 3.77 -46.15% 1.48 3.60 -58.89% 3.95 3.59 10.03% 3.77 2.74 37.59%
PATM 4.37% 10.60% 3.39% 10.75% 9.41% 10.84% 9.75% 12.06%
EPS 1.60 2.98 -46.31% 1.76 2.85 -38.25% 3.30 2.94 12.24% 3.07 2.25 36.44%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 164.52 137.88 115.45 110.15 117.34 122.60 111.51 82.46 67.28 77.79 73.25 Net Sales Growth 33.23% 19.43% 4.81% -6.13% -4.29% 9.95% 35.23% 22.56% -13.51% 6.20% Cost Of Goods Sold 89.55 52.66 43.51 47.48 59.66 69.26 49.05 37.50 29.05 37.26 34.57 Gross Profit 74.97 85.22 71.93 62.67 57.69 53.34 62.46 44.96 38.23 40.53 38.68 GP Margin 45.57% 61.81% 62.30% 56.90% 49.16% 43.51% 56.01% 54.52% 56.82% 52.10% 52.81% Total Expenditure 138.61 113.27 91.35 90.12 99.22 105.14 94.73 70.87 61.75 72.75 68.02 Power & Fuel Cost - 5.67 5.86 2.68 2.90 2.11 2.78 2.35 2.76 3.29 2.63 % Of Sales - 4.11% 5.08% 2.43% 2.47% 1.72% 2.49% 2.85% 4.10% 4.23% 3.59% Employee Cost - 18.57 14.50 8.79 9.29 8.09 9.05 6.65 4.86 5.42 4.71 % Of Sales - 13.47% 12.56% 7.98% 7.92% 6.60% 8.12% 8.06% 7.22% 6.97% 6.43% Manufacturing Exp. - 27.11 18.12 26.48 21.99 19.85 26.99 16.76 17.05 17.69 17.56 % Of Sales - 19.66% 15.70% 24.04% 18.74% 16.19% 24.20% 20.33% 25.34% 22.74% 23.97% General & Admin Exp. - 5.19 4.92 2.63 3.61 3.29 3.74 4.77 3.56 3.68 3.42 % Of Sales - 3.76% 4.26% 2.39% 3.08% 2.68% 3.35% 5.78% 5.29% 4.73% 4.67% Selling & Distn. Exp. - 2.92 3.36 1.71 1.45 2.33 3.11 2.84 3.92 4.46 4.08 % Of Sales - 2.12% 2.91% 1.55% 1.24% 1.90% 2.79% 3.44% 5.83% 5.73% 5.57% Miscellaneous Exp. - 1.16 1.07 0.34 0.32 0.22 0.01 0.01 0.55 0.96 4.08 % Of Sales - 0.84% 0.93% 0.31% 0.27% 0.18% 0.01% 0.01% 0.82% 1.23% 1.46% EBITDA 25.91 24.61 24.10 20.03 18.12 17.46 16.78 11.59 5.53 5.04 5.23 EBITDA Margin 15.75% 17.85% 20.87% 18.18% 15.44% 14.24% 15.05% 14.06% 8.22% 6.48% 7.14% Other Income 2.11 2.46 1.72 0.75 1.91 3.66 1.89 0.31 0.70 1.10 0.61 Interest 3.38 3.39 1.94 1.51 0.93 1.38 2.71 3.61 3.62 3.92 4.05 Depreciation 6.85 6.35 5.77 2.52 2.50 2.21 2.06 1.92 1.90 2.10 1.61 PBT 17.81 17.33 18.10 16.75 16.60 17.52 13.90 6.36 0.71 0.12 0.18 Tax 3.57 2.33 3.20 4.26 4.34 5.50 3.79 1.20 0.23 -0.32 0.08 Tax Rate 20.04% 13.44% 17.68% 25.43% 26.14% 31.39% 27.27% 18.87% 32.39% -266.67% 44.44% PAT 14.25 15.00 14.91 12.49 12.26 12.03 10.11 5.16 0.48 0.44 0.09 PAT before Minority Interest 14.25 15.00 14.91 12.49 12.26 12.03 10.11 5.16 0.48 0.44 0.09 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 8.66% 10.88% 12.91% 11.34% 10.45% 9.81% 9.07% 6.26% 0.71% 0.57% 0.12% PAT Growth 3.94% 0.60% 19.38% 1.88% 1.91% 18.99% 95.93% 975.00% 9.09% 388.89% EPS 11.22 11.81 11.74 9.83 9.65 9.47 7.96 4.06 0.38 0.35 0.07

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Net Sales 170.64 140.87 115.45 112.72 125.50 122.60 Net Sales Growth 36.57% 22.02% 2.42% -10.18% 2.37% Cost Of Goods Sold 90.64 53.25 43.51 50.06 65.62 69.26 Gross Profit 80.00 87.62 71.93 62.65 59.89 53.34 GP Margin 46.88% 62.20% 62.30% 55.58% 47.72% 43.51% Total Expenditure 147.67 116.53 91.36 93.04 106.03 105.14 Power & Fuel Cost - 5.67 5.86 2.68 2.90 2.11 % Of Sales - 4.02% 5.08% 2.38% 2.31% 1.72% Employee Cost - 20.15 14.50 9.00 9.52 8.09 % Of Sales - 14.30% 12.56% 7.98% 7.59% 6.60% Manufacturing Exp. - 27.14 18.12 26.48 21.99 19.85 % Of Sales - 19.27% 15.70% 23.49% 17.52% 16.19% General & Admin Exp. - 5.67 4.93 2.76 3.92 3.29 % Of Sales - 4.02% 4.27% 2.45% 3.12% 2.68% Selling & Distn. Exp. - 3.48 3.36 1.71 1.77 2.33 % Of Sales - 2.47% 2.91% 1.52% 1.41% 1.90% Miscellaneous Exp. - 1.18 1.07 0.34 0.32 0.22 % Of Sales - 0.84% 0.93% 0.30% 0.25% 0.18% EBITDA 22.98 24.34 24.09 19.68 19.47 17.46 EBITDA Margin 13.47% 17.28% 20.87% 17.46% 15.51% 14.24% Other Income 2.11 2.46 1.72 0.75 1.94 3.66 Interest 3.38 3.39 1.94 1.51 0.93 1.38 Depreciation 6.94 6.37 5.77 2.52 2.50 2.21 PBT 14.77 17.05 18.09 16.39 17.98 17.52 Tax 3.56 2.32 3.20 4.26 4.69 5.50 Tax Rate 24.10% 13.61% 17.69% 25.99% 26.08% 31.39% PAT 11.23 14.73 14.90 12.13 13.29 12.03 PAT before Minority Interest 12.33 14.73 14.90 12.13 13.29 12.03 Minority Interest 1.10 0.00 0.00 0.00 0.00 0.00 PAT Margin 6.58% 10.46% 12.91% 10.76% 10.59% 9.81% PAT Growth -18.03% -1.14% 22.84% -8.73% 10.47% EPS 8.84 11.60 11.73 9.55 10.46 9.47

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 193.80 148.04 134.35 122.48 86.63 74.61 26.78 17.91 17.18 16.54 Share Capital 12.65 12.22 12.22 12.22 11.70 11.70 10.52 9.99 9.51 8.91 Total Reserves 181.14 135.82 122.14 110.26 74.93 62.91 15.49 7.92 7.39 7.36 Non-Current Liabilities 0.66 6.04 7.84 3.58 1.42 1.73 3.95 4.87 6.74 2.43 Secured Loans 0.87 5.07 6.40 2.36 0.02 0.14 2.46 3.52 4.59 0.16 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 1.66 1.46 1.16 1.06 0.98 1.18 0.85 0.61 1.49 1.28 Current Liabilities 80.46 71.13 50.27 50.40 48.54 41.21 42.67 37.24 44.74 45.61 Trade Payables 45.55 41.74 29.58 31.96 30.57 21.80 22.31 18.76 26.52 24.44 Other Current Liabilities 7.21 5.03 4.99 5.59 0.78 0.87 4.81 3.20 2.54 5.92 Short Term Borrowings 23.31 19.27 10.93 7.62 11.61 14.24 14.09 14.76 15.56 15.13 Short Term Provisions 4.39 5.09 4.78 5.23 5.58 4.30 1.46 0.53 0.12 0.13 Total Liabilities 274.92 225.21 192.46 176.46 136.59 117.55 73.40 60.02 68.66 64.58 Net Block 92.36 92.48 89.64 33.69 24.38 25.34 19.05 19.10 19.84 21.76 Gross Block 130.12 124.26 115.66 57.74 46.58 45.78 37.66 35.79 34.94 34.32 Accumulated Depreciation 37.76 31.78 26.02 24.05 22.20 20.45 18.61 16.69 15.10 12.55 Non Current Assets 109.98 96.48 93.37 77.17 40.01 26.46 20.02 19.42 20.15 22.63 Capital Work in Progress 0.00 0.00 0.00 40.50 14.76 0.28 0.45 0.00 0.00 0.55 Non Current Investment 4.08 2.06 2.06 2.06 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 1.09 0.87 0.78 0.63 0.58 0.57 0.52 0.32 0.32 0.31 Other Non Current Assets 12.46 1.08 0.90 0.29 0.29 0.28 0.00 0.00 0.00 0.00 Current Assets 157.97 120.98 92.43 97.24 96.17 90.99 53.38 40.60 48.51 41.95 Current Investments 0.00 0.00 0.00 0.00 0.00 0.07 0.07 0.02 0.02 0.02 Inventories 45.06 27.01 5.20 16.96 15.26 14.23 13.79 11.14 13.46 12.84 Sundry Debtors 60.23 61.18 49.75 43.93 43.37 38.42 25.69 16.09 26.51 20.41 Cash & Bank 20.44 3.81 3.08 2.23 8.52 22.66 2.97 2.72 2.29 2.71 Other Current Assets 32.25 20.28 22.95 21.52 29.01 15.60 10.87 10.63 6.21 5.98 Short Term Loans & Adv. 10.20 8.69 11.44 12.60 14.41 1.50 9.01 8.45 4.40 3.96 Net Current Assets 77.51 49.85 42.16 46.85 47.62 49.78 10.71 3.35 3.77 -3.66 Total Assets 274.91 225.20 192.46 176.45 136.60 117.55 73.40 60.02 68.66 64.58

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Shareholder's Funds 193.29 146.47 132.89 121.22 86.63 Share Capital 12.65 12.22 12.22 12.22 11.70 Total Reserves 180.64 134.25 120.67 109.00 74.93 Non-Current Liabilities 0.65 6.04 7.84 3.58 1.42 Secured Loans 0.87 5.07 6.40 2.36 0.02 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 1.66 1.46 1.16 1.06 0.98 Current Liabilities 82.57 72.69 53.27 56.48 48.54 Trade Payables 47.59 43.30 32.21 37.38 30.57 Other Current Liabilities 7.28 5.03 4.90 5.91 0.78 Short Term Borrowings 23.31 19.27 10.93 7.62 11.61 Short Term Provisions 4.39 5.09 5.23 5.57 5.58 Total Liabilities 276.63 225.20 194.00 181.28 136.59 Net Block 92.66 92.48 89.64 33.69 24.38 Gross Block 130.43 124.26 115.66 57.74 46.58 Accumulated Depreciation 37.77 31.78 26.02 24.05 22.20 Non Current Assets 106.22 94.42 91.31 75.11 40.01 Capital Work in Progress 0.00 0.00 0.00 40.50 14.76 Non Current Investment 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 1.11 0.87 0.78 0.63 0.58 Other Non Current Assets 12.46 1.08 0.90 0.29 0.29 Current Assets 163.36 123.04 96.03 104.13 96.17 Current Investments 0.00 0.00 0.00 0.00 0.00 Inventories 45.06 27.01 5.20 16.96 15.26 Sundry Debtors 65.26 63.22 52.55 49.96 43.37 Cash & Bank 20.78 3.82 3.89 3.09 8.52 Other Current Assets 32.27 20.28 22.95 21.52 29.01 Short Term Loans & Adv. 10.22 8.69 11.44 12.60 14.41 Net Current Assets 80.79 50.35 42.76 47.65 47.62 Total Assets 276.64 225.20 194.00 181.28 136.60

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity -3.50 4.81 12.98 11.71 4.30 -5.45 3.59 6.21 -3.27 5.14 PBT 17.33 18.10 16.75 16.60 17.35 13.90 6.36 0.48 0.44 0.09 Adjustment 8.56 7.04 3.43 2.81 2.24 4.28 4.88 5.12 4.38 4.52 Changes in Working Capital -26.27 -17.13 -2.74 -3.35 -11.29 -23.14 -7.65 0.61 -8.09 0.53 Cash after chg. in Working capital -0.38 8.01 17.44 16.06 8.30 -4.95 3.59 6.21 -3.27 5.14 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -3.12 -3.20 -4.46 -4.35 -4.00 -0.50 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -7.54 -8.47 -17.81 -39.35 -14.76 -7.99 -2.30 -1.05 0.12 -0.84 Net Fixed Assets -5.86 -8.60 -17.42 -36.90 -15.28 -7.95 -2.32 -0.85 -0.07 -0.74 Net Investments -2.02 0.00 0.00 -2.06 0.07 0.00 -0.05 0.00 0.00 0.00 Others 0.34 0.13 -0.39 -0.39 0.45 -0.04 0.07 -0.20 0.19 -0.10 Cash from Financing Activity 27.67 4.39 5.68 21.36 -3.69 33.14 -1.04 -4.73 2.74 -3.68 Net Cash Inflow / Outflow 16.63 0.73 0.85 -6.29 -14.15 19.70 0.25 0.42 -0.42 0.62 Opening Cash & Equivalents 3.81 3.08 2.23 8.52 22.66 2.97 2.72 2.29 2.71 2.09 Closing Cash & Equivalent 20.44 3.81 3.08 2.23 8.52 22.66 2.97 2.72 2.29 2.71

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Cash From Operating Activity -6.29 4.11 12.77 12.80 4.30 PBT 17.05 18.09 16.39 17.98 17.35 Adjustment 8.56 7.04 3.43 2.81 2.24 Changes in Working Capital -28.78 -17.82 -2.59 -3.64 -11.29 Cash after chg. in Working capital -3.17 7.31 17.23 17.15 8.30 Interest Paid 0.00 0.00 0.00 0.00 0.00 Tax Paid -3.12 -3.20 -4.46 -4.35 -4.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -5.88 -8.47 -17.81 -37.29 -14.76 Net Fixed Assets -5.86 -8.60 -17.42 -36.90 Net Investments -2.02 0.00 0.00 -2.06 Others 2.00 0.13 -0.39 1.67 Cash from Financing Activity 29.13 4.30 5.84 19.06 -3.69 Net Cash Inflow / Outflow 16.95 -0.07 0.80 -5.43 -14.15 Opening Cash & Equivalents 3.82 3.89 3.09 8.52 22.66 Closing Cash & Equivalent 20.78 3.82 3.89 3.09 8.52

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 147.68 114.84 104.52 98.58 73.69 63.68 24.73 17.92 17.77 18.26 ROA 6.00% 7.14% 6.77% 7.83% 9.46% 10.59% 7.74% 0.75% 0.66% 0.15% ROE 9.17% 11.12% 10.06% 11.86% 14.96% 20.12% 23.50% 2.76% 2.66% 0.59% ROCE 10.95% 12.82% 13.12% 15.26% 20.22% 24.91% 24.10% 11.36% 11.58% 13.09% Fixed Asset Turnover 1.08 0.96 1.27 2.25 2.65 2.68 2.25 1.90 2.25 2.15 Receivable days 160.69 175.37 155.22 135.78 121.75 104.83 92.47 115.48 109.77 96.18 Inventory Days 95.39 50.92 36.72 50.11 43.90 45.82 55.17 66.68 61.53 69.37 Payable days 302.49 299.07 236.52 114.92 91.29 86.27 110.47 140.55 129.01 127.06 Cash Conversion Cycle -46.42 -72.78 -44.58 70.96 74.36 64.38 37.17 41.61 42.30 38.49 Total Debt/Equity 0.14 0.18 0.15 0.10 0.14 0.19 0.68 1.14 1.23 0.95 Interest Cover 6.11 10.33 12.08 18.83 13.68 6.13 2.76 1.20 1.03 1.04

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Book Value (Rs.) 147.21 113.56 103.33 97.55 73.69 ROA 5.87% 7.11% 6.46% 8.36% 8.80% ROE 9.06% 11.25% 9.89% 12.94% 13.95% ROCE 10.86% 12.94% 12.99% 16.54% 19.30% Fixed Asset Turnover 1.11 0.96 1.30 2.41 2.63 Receivable days 166.45 183.01 165.97 135.71 129.12 Inventory Days 93.37 50.92 35.88 46.85 45.43 Payable days 311.49 316.67 253.69 117.21 106.58 Cash Conversion Cycle -51.67 -82.73 -51.84 65.35 67.97 Total Debt/Equity 0.14 0.19 0.15 0.10 0.14 Interest Cover 6.03 10.32 11.85 20.30 13.68

Top Investors:

pharmadanica a/s

ginnerup capital aps

investor education and protection fund (iepf)

Annual Reports:

News Update:

Medicamen Biotech - Quarterly Results
12th Feb 2024, 16:00 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback